Education
About Us
Working with TipRanks
Follow Us
Aim Immunotech Inc. (AIM)
XASE:AIM
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 170.00K | $ 202.00K | $ 141.00K | $ 135.00K | $ 163.00K |
| Gross Profit | $ 139.00K | $ 160.00K | $ 565.00K | $ -715.00K | $ -643.00K |
| Operating Income | $ -19.77M | $ -31.92M | $ -19.92M | $ -18.84M | $ -15.15M |
| EBITDA | $ -16.49M | $ -28.72M | $ -19.87M | $ -18.29M | $ -12.99M |
| Net Income | $ -17.32M | $ -28.96M | $ -19.45M | $ -19.13M | $ -14.40M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.98M | $ 13.07M | $ 34.19M | $ 48.27M | $ 39.00M |
| Total Assets | $ 8.61M | $ 19.38M | $ 40.49M | $ 57.70M | $ 111.02M |
| Total Debt | $ 2.94M | $ 718.00K | $ 837.00K | $ 149.00K | $ 2.29M |
| Net Debt | $ 1.24M | $ -4.72M | $ -26.22M | $ -31.94M | $ -36.22M |
| Total Liabilities | $ 9.93M | $ 9.15M | $ 2.02M | $ 820.00K | $ 49.73M |
| Stockholders' Equity | $ -1.32M | $ 10.23M | $ 38.47M | $ 56.88M | $ 61.29M |
| Cash Flow | |||||
| Free Cash Flow | $ -14.91M | $ -21.85M | $ -16.38M | $ -14.60M | $ -10.96M |
| Operating Cash Flow | $ -14.89M | $ -21.27M | $ -16.11M | $ -13.96M | $ -10.37M |
| Investing Cash Flow | $ 4.71M | $ -832.00K | $ 10.99M | $ -631.00K | $ -9.16M |
| Financing Cash Flow | $ 6.44M | $ 485.00K | $ 80.00K | $ 8.19M | $ 56.56M |